American Indians have a high prevalence of both type 2 diabetes and impaired glucose tolerance, and one could speculate that carriers of the TRPM3 SNV may benefit from using preferentially these medications for diabetes prevention. The gene discussed is TRPM3; the disease is type 2 diabetes mellitus.